Cargando…
Novel biomanufacturing platform for large-scale and high-quality human T cells production
The adoptive transfer of human T cells or genetically-engineered T cells with cancer-targeting receptors has shown tremendous promise for eradicating tumors in clinical trials. The objective of this study was to develop a novel T cell biomanufacturing platform using stirred-tank bioreactor for large...
Autores principales: | Ou, Jianfa, Si, Yingnan, Tang, Yawen, Salzer, Grace E., Lu, Yun, Kim, Seulhee, Qin, Hongwei, Zhou, Lufang, Liu, Xiaoguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480708/ https://www.ncbi.nlm.nih.gov/pubmed/31044002 http://dx.doi.org/10.1186/s13036-019-0167-2 |
Ejemplares similares
-
Antibody–Drug Conjugate to Treat Meningiomas
por: Chen, Kai, et al.
Publicado: (2021) -
Anti-SSTR2 Antibody-drug Conjugate for Neuroendocrine Tumor Therapy
por: Si, Yingnan, et al.
Publicado: (2020) -
Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapy
por: Si, Yingnan, et al.
Publicado: (2020) -
Biorhizome: A Biosynthetic Platform for Colchicine Biomanufacturing
por: Sivakumar, Ganapathy, et al.
Publicado: (2017) -
Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers
por: Si, Yingnan, et al.
Publicado: (2022)